Redwood Wealth Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Redwood Wealth Management Group's PFE Position: Q2 2026 in Review
Redwood Wealth Management Group sold out of Pfizer (PFE) in Q2 2026, closing a stake of 17,262 shares — an estimated $485K sold.
Redwood Wealth Management Group first reported a position in PFE in Q4 2022 and held it in 14 quarters. The position peaked at $908K in Q4 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Redwood Wealth Management Group reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Redwood Wealth Management Group sold 17,262 Pfizer shares in Q2 2026, an estimated $485K.
- Redwood Wealth Management Group first reported a position in Pfizer in Q4 2022 and held it in 14 quarters.
- Redwood Wealth Management Group's Pfizer position peaked at $908K in Q4 2022.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Redwood Wealth Management Group's 13F filing for Q2 2026.